244 related articles for article (PubMed ID: 11917163)
1. Cutaneous T-cell lymphoproliferative disorders: approach for the surgical pathologist: recent advances and clarification of confused issues.
Liu V; McKee PH
Adv Anat Pathol; 2002 Mar; 9(2):79-100. PubMed ID: 11917163
[TBL] [Abstract][Full Text] [Related]
2. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions.
Kempf W; Dummer R; Burg G
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473
[TBL] [Abstract][Full Text] [Related]
3. T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders.
Zelickson BD; Peters MS; Muller SA; Thibodeau SN; Lust JA; Quam LM; Pittelkow MR
J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):787-96. PubMed ID: 1839392
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
Kikuchi A; Nishikawa T
Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
[TBL] [Abstract][Full Text] [Related]
5. Epidermotropic CD8 positive lymphoproliferative diseases: histological and immunophenotypic similarities but markedly differing clinical behaviour.
Paton DJ; Van Vliet C; Prasad Kumarasinghe S; Chan JJ; Wood BA
Pathology; 2016 Dec; 48(7):733-736. PubMed ID: 27814904
[No Abstract] [Full Text] [Related]
6. C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment.
Geller S; Hollmann TJ; Horwitz SM; Myskowski PL; Pulitzer M
Histopathology; 2020 Jan; 76(2):222-232. PubMed ID: 31355940
[TBL] [Abstract][Full Text] [Related]
7. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types.
Kinney MC; Jones D
Am J Clin Pathol; 2007 May; 127(5):670-86. PubMed ID: 17439828
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous pseudolymphomas: classification and differential diagnosis.
Rijlaarsdam JU; Willemze R
Semin Dermatol; 1994 Sep; 13(3):187-96. PubMed ID: 7986687
[TBL] [Abstract][Full Text] [Related]
11. The clinico-pathological spectrum of primary cutaneous lymphoma other than mycosis fungoides/Sezary syndrome.
Oschlies I; King RL; Dotlic S; Montes-Moreno S; Ponzoni M; Traverse-Glehen A; Calaminici M; Ferry JA; Ott G; Goodlad JR
Virchows Arch; 2020 May; 476(5):683-699. PubMed ID: 31781845
[TBL] [Abstract][Full Text] [Related]
12. TCR-γ expression in primary cutaneous T-cell lymphomas.
Rodríguez-Pinilla SM; Ortiz-Romero PL; Monsalvez V; Tomás IE; Almagro M; Sevilla A; Camacho G; Longo MI; Pulpillo Á; Diaz-Pérez JA; Montes-Moreno S; Castro Y; Echevarría B; Trébol I; Gonzalez C; Sánchez L; Otín AP; Requena L; Rodríguez-Peralto JL; Cerroni L; Piris MÁ
Am J Surg Pathol; 2013 Mar; 37(3):375-84. PubMed ID: 23348211
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic difficulties in 'non-mycotic' cutaneous lymphoproliferative diseases.
Slater DN
Histopathology; 1992 Sep; 21(3):203-13. PubMed ID: 1398519
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
16. [Cutaneous lymphomas: new entities and rare variants].
Kempf W; Mitteldorf C
Pathologe; 2015 Feb; 36(1):62-9. PubMed ID: 25589355
[TBL] [Abstract][Full Text] [Related]
17. [Rare variants of cutaneous T-cell lymphomas].
Goerdt S; Trautmann C; Kütting B; Ramaker J; Schmuth M; Thiel E; Luger T; Stein H; Orfanos CE
Hautarzt; 1996 Feb; 47(2):96-105. PubMed ID: 8868452
[TBL] [Abstract][Full Text] [Related]
18. Nodal Involvement by CD30
Lezama LS; Gratzinger D
Arch Pathol Lab Med; 2018 Jan; 142(1):139-142. PubMed ID: 29257929
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.
Massone C; Chott A; Metze D; Kerl K; Citarella L; Vale E; Kerl H; Cerroni L
Am J Surg Pathol; 2004 Jun; 28(6):719-35. PubMed ID: 15166664
[TBL] [Abstract][Full Text] [Related]
20. Signet ring cell primary cutaneous CD30+ lymphoproliferative disorder presenting as a monomorphic T-cell posttransplant lymphoproliferative disease.
Papalas JA; Kulbacki EL; Park HK; Howell ER
Am J Dermatopathol; 2012 Oct; 34(7):e94-6. PubMed ID: 22534639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]